Founded in 1998, SocraTec R&D is now a leading full-service Contract Research Organisation (CRO) with associated phase I Clinical Pharmacology Unit (CPU). Based in Germany, we are providing comprehensive clinical research solutions for services in all key areas of the drug development process for companies from the pharmaceutical, biotechnology and medical industries. By help of our extensive network of qualified employees, researchers and partners we are performing the following services: Design Development, Expert Statements, Scientific Advice, Clinical Trial Project Management, Quality Assurance, Monitoring, Data Management, Biostatistics, Medical Writing. SocraTec R&D is looking back at more than 20 years of experience in clinical trials (Phase I-IV), BA / BE studies (Bioequivalence studies), proof-of-concept studies and clinical endpoint studies. Our state-of-the-art 60 bed phase I CPU includes an intensive monitoring unit with cardiovascular surveillance, specifically designed for first-in-human studies and other studies requiring a high-security level. Our excellence is a result of our employees‘ relentless efforts, profound know-how and high motivation. We believe in a culture where people take pride in working together to better meet our client’s needs, a culture that fosters personal growth and professional development.